Abbott, WARF End Zemplar Patent Suit Against Anchen

Law360, New York (March 23, 2011, 7:17 PM EDT) -- Abbott Laboratories and the Wisconsin Alumni Research Foundation on Wednesday dropped a patent infringement suit in Delaware seeking to stop Anchen Pharmaceuticals Inc. from launching a generic version of kidney disease treatment Zemplar.

Judge Gregory M. Sleet of the U.S. District Court for the District of Delaware approved a joint stipulation filed by the parties Monday in which they agreed to dismiss all claims, counterclaims and affirmative defenses in the suit without prejudice. The companies also indicated that each would cover its own costs and attorneys’...
To view the full article, register now.